BioTelemetry, Inc. Reports Third Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- Wall Street ends lower on semiconductor selloff as AI spending concerns mount
- Chip stocks plunge, but bargain-hunters stem losses in other tech names
- FedEx falls 4% as FY2027 profit forecast misses expectations despite Q4 beat
- Oil prices finish 1% lower as investors focus on Hormuz flows after peace talks
- South Korea leveraged ETF crisis sparks global chip selloff
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Needham Starts NeoVolta (NEOV) at Buy
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
BioTelemetry (BEAT) Tops Q3 EPS by 7c
October 29, 2020 4:38 PM EDTBioTelemetry (NASDAQ: BEAT) reported Q3 EPS of $0.45, $0.07 better than the analyst estimate of $0.38. Revenue for the quarter came in at $114.7 million versus the consensus estimate of $105.1 million.
Joseph H. Capper, President and Chief Executive Officer of BioTelemetry, Inc., commented:
We are pleased to announce that we achieved solid third quarter... More
